MGAE / MGA1-MMYASTHENIA GRAVIS ADULT EVALUATION

Useful for the initial evaluation of patients aged 20 or older with symptoms and signs of acquired myasthenia gravis (MG).Bone marrow transplant recipients with suspected graft-versus-host disease, particularly if weakness has appeared.Confirming that a recently acquired neurological disorder has an autoimmune basis (eg, MG).Providing a quantitative baseline for future comparisons in monitoring a patient's clinical course and the response to immunomodulatory treatment.Raising likelihood of neoplasia

Specimen

3mL serum from a plain red top or serum gel tube. Patient should have no general anesthetic or muscle-relaxant drugs in the previous 24 hours